Publications & Works

Publication Network
Articles 142
All (142)
SCI-E, SSCI, AHCI (125)
SCI-E, SSCI, AHCI, ESCI (127)
ESCI (2)
Scopus (122)
TRDizin (4)
Other Publications (13)

1. Can we cure Behçet syndrome?

Yazici H., HATEMİ G., Yazici Y.
Current Opinion in Immunology , vol.95, 2025 (SCI-Expanded) identifier identifier

2. A probable ecologic bias in the article on the progression of knee osteoarthritis: comment on the article by Lo et al

Yazici H., Ogun H., Yazici Y.
ARTHRITIS & RHEUMATOLOGY , vol.75, pp.1683-0, 2023 (SCI-Expanded) identifier identifier identifier

3. Infliximab for vascular involvement in Behcet's syndrome

HATEMİ G., Tukek N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., UYGUNOĞLU U., et al.
CLINICAL IMMUNOLOGY , vol.253, 2023 (SCI-Expanded) identifier identifier identifier

4. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., Yurdakul S., HAMURYUDAN V., et al.
RHEUMATOLOGY , vol.62, pp.9-18, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

5. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., Tukek N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , pp.3098-3099, 2022 (SCI-Expanded) identifier

6. Emergence of new manifestations during infliximab treatment in Behcet's syndrome

TÜKEK N. B., ESATOĞLU S. N., HATEMİ G., Caliskan E. B., Ozyazgan Y., UÇAR D., et al.
RHEUMATOLOGY , vol.61, no.9, pp.3746-3753, 2022 (SCI-Expanded) identifier identifier identifier

7. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Ozdede A., Yazici H.
NEW ENGLAND JOURNAL OF MEDICINE , vol.386, no.18, pp.1766, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

8. Core Set of Domains for Outcome Measures in Behcet's Syndrome

HATEMİ G., Meara A., Ozguler Y., DİRESKENELİ R. H., Mahr A., Shea B., et al.
ARTHRITIS CARE & RESEARCH , vol.74, pp.691-699, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

9. Behcet syndrome

Yazici Y., HATEMİ G., Bodaghi B., Cheon J. H., Suzuki N., Ambrose N., et al.
NATURE REVIEWS DISEASE PRIMERS , vol.7, no.1, 2021 (SCI-Expanded) identifier identifier

10. The winter of my discontent

Yazici H.
TURKISH ARCHIVES OF PEDIATRICS , vol.56, no.3, pp.177-178, 2021 (ESCI) identifier identifier identifier

11. Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide

Gurcan M., Esatoglu S. N., HAMURYUDAN V., Saygin D., UĞURLU S., SEYAHİ E., et al.
RHEUMATOLOGY , vol.59, no.9, pp.2264-2271, 2020 (SCI-Expanded) identifier identifier identifier

12. The P-value crisis and the issue of causality

Yazici H.
RHEUMATOLOGY , vol.59, no.7, pp.1467-1468, 2020 (SCI-Expanded) identifier identifier identifier

13. Comment on: Clinical course of acute deep vein thrombosis of the legs in Behcet's syndrome: reply

ÖZGÜLER Y., HATEMİ G., Cetinkaya F., Tascilar K., HAMURYUDAN V., UĞURLU S., et al.
RHEUMATOLOGY , vol.59, no.4, pp.914-915, 2020 (SCI-Expanded) identifier identifier identifier

14. Clinical course of acute deep vein thrombosis of the legs in Behcet's syndrome

ÖZGÜLER Y., HATEMİ G., Cetinkaya F., Tascilar K., HAMURYUDAN V., UĞURLU S., et al.
RHEUMATOLOGY , vol.59, no.4, pp.799-806, 2020 (SCI-Expanded) identifier identifier identifier

15. Increased vein wall thickness in Behcet disease

Seyahi E., Gjoni M., Durmaz E. S., Akbas S., SÜT N., Dikici A. S., et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS , vol.7, no.5, pp.677-686, 2019 (SCI-Expanded) identifier identifier identifier

16. Assessment of deep venous thrombosis in the lower extremity in Behcet's syndrome: MR venography versus Doppler ultrasonography

Tutar B., Kantarci F., Cakmak O. S., Yazici H., Seyahi E.
INTERNAL AND EMERGENCY MEDICINE , vol.14, no.5, pp.705-711, 2019 (SCI-Expanded) identifier identifier identifier

17. Clinical Characteristics of Older Age-Onset Behcet Syndrome Patients

Guzelant G., Ozyazgan Y., Mat C., Hamuryudan V., Yazici H., Seyahi E.
ARTHRITIS & RHEUMATOLOGY , vol.70, 2018 (SCI-Expanded) identifier

18. Acknowledged Biostatistical Help and the Quality of Statistical Analyses in Randomized Controlled Trials in Rheumatology

Dincses E., Guzelant G., Hatemi G., Yazici H.
ARTHRITIS & RHEUMATOLOGY , vol.70, 2018 (SCI-Expanded) identifier

19. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.
ARTHRITIS & RHEUMATOLOGY , vol.70, 2018 (SCI-Expanded) identifier

20. Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration

Ozguler Y., Yazici Y., Hatemi G., Tascilar K., Yazici H.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8, pp.894-901, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

21. Behcet syndrome: a contemporary view

Yazici H., Seyahi E., Hatemi G., Yazici Y.
NATURE REVIEWS RHEUMATOLOGY , vol.14, no.2, pp.107-119, 2018 (SCI-Expanded) identifier identifier identifier

22. Developing a Core Set of Outcome Measures for Behcet Disease: Report from OMERACT 2016

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., et al.
JOURNAL OF RHEUMATOLOGY , vol.44, no.11, pp.1750-1753, 2017 (SCI-Expanded) identifier identifier identifier

23. Cardiovascular Risk Factors and Comorbid Diseases in Takayasu's Arteritis

Masyan H., Esatoglu S. N., Celik A. M., Hamuryudan V., Yazici H., Seyahi E.
ARTHRITIS & RHEUMATOLOGY , vol.69, 2017 (SCI-Expanded) identifier

24. Surgical Therapies in the Treatment of Pulmonary Artery Involvement in Behcet's Syndrome

Tuzun H., Guzelant G., Demirhan O., Oz B., Fresko I., Hamuryudan V., et al.
ARTHRITIS & RHEUMATOLOGY , vol.69, 2017 (SCI-Expanded) identifier

25. Missing Information About Disease Controls: Comment on the Article by Mangnus et al

Esatoglu S. N., Seyahi E., Yazici H.
ARTHRITIS & RHEUMATOLOGY , vol.69, no.3, pp.678, 2017 (SCI-Expanded) identifier identifier identifier

26. Identifying Core Domains for BehcEt's Syndrome Trials: An International Physician and Patient Delphi Exercise

Meara A., Ozguler Y., Mahr A., Direskeneli H., Gül A., Yazici Y., et al.
ARTHRITIS & RHEUMATOLOGY , vol.68, 2016 (SCI-Expanded) identifier

27. a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.
ARTHRITIS & RHEUMATOLOGY , vol.68, 2016 (SCI-Expanded) identifier

28. Diagnostic criteria as separate from classification criteria: a perpetual motion machine? Comment on the article by Aggarwal et al

Yazici H., Hatemi G., Yazici Y.
ARTHRITIS CARE & RESEARCH , vol.68, no.7, pp.1049, 2016 (SCI-Expanded) identifier identifier identifier

29. Behcet syndrome: the vascular cluster

Yazici H., Seyahi E.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.5, pp.1277-1280, 2016 (SCI-Expanded) identifier identifier identifier

30. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behcet Syndrome: Report from OMERACT 2014

Hatemi G., Ozguler Y., Direskeneli H., Mahr A., Gul A., Levı V., et al.
JOURNAL OF RHEUMATOLOGY , vol.42, pp.2436-2441, 2015 (SCI-Expanded) identifier identifier identifier

31. Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration

Ozguler Y., Yazici Y., Hatemi G., Yazici H.
ARTHRITIS & RHEUMATOLOGY , vol.67, 2015 (SCI-Expanded) identifier

32. Are sample sizes of randomized clinical trials in rheumatoid arthritis too large?

Celik S., Yazici Y., Yazici H.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.44, no.11, pp.1034-1044, 2014 (SCI-Expanded) identifier identifier identifier

33. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.
ARTHRITIS & RHEUMATOLOGY , vol.66, 2014 (SCI-Expanded) identifier

34. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.
ARTHRITIS & RHEUMATOLOGY , vol.66, 2014 (SCI-Expanded) identifier

35. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Melikoglu M., Ozguler Y., Ugurlu S., Cetinkaya F., Tascilar K., Seyahi E., et al.
ARTHRITIS & RHEUMATOLOGY , vol.66, 2014 (SCI-Expanded) identifier

36. Interferon Alfa-Associated Depression in Patients with Behcet's Syndrome.

Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.
ARTHRITIS & RHEUMATOLOGY , vol.66, 2014 (SCI-Expanded) identifier

37. Effect of Apremilast on Quality of Life and Physical Function in Patients with Behcet's Syndrome.

Hatemi G., Melikoglu M., Tunc R., Korkmaz C., ÖZTÜRK B. T., Mat C., et al.
ARTHRITIS & RHEUMATOLOGY , vol.66, 2014 (SCI-Expanded) identifier

38. There was less self-critique among basic than in clinical science articles in three rheumatology journals

Yazici H., Gogus F., Esen F., Yazici Y.
JOURNAL OF CLINICAL EPIDEMIOLOGY , vol.67, no.6, pp.654-657, 2014 (SCI-Expanded) identifier identifier identifier

39. No appreciable decrease in fertility in Behcet's syndrome

Uzunaslan D., Saygin C., Hatemi G., Tascilar K., Yazici H.
RHEUMATOLOGY , vol.53, no.5, pp.828-833, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

40. Outcome Measures Used in Clinical Trials for Behcet Syndrome: A Systematic Review

Hatemi G., Merkel P. A., Hamuryudan V., Boers M., Direskeneli H., Aydin S. Z., et al.
JOURNAL OF RHEUMATOLOGY , vol.41, no.3, pp.599-612, 2014 (SCI-Expanded) identifier identifier identifier

41. Criteria for Behcet's disease with reflections on all disease criteria

Yazici H., Yazici Y.
JOURNAL OF AUTOIMMUNITY , pp.104-107, 2014 (SCI-Expanded) identifier identifier identifier

42. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome

Ozguler Y., Melikoglu M., Ugurlu S., Cetinkaya F., Tascilar E. K., Seyahi E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded) identifier

43. Tuberculosis Screening Before and During Treatment with Tumor Necrosis Factor Antagonists: Something Old, Something New

Hatemi G., Yazici H.
JOURNAL OF RHEUMATOLOGY , vol.40, no.12, pp.1938-1940, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

44. Neoplasms as the leading cause of death among patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et al

Yazici H., Tascilar K., Yazici Y.
ARTHRITIS AND RHEUMATISM , vol.65, no.6, pp.1670, 2013 (SCI-Expanded) identifier identifier identifier

45. Are we content that risk of cancer is not appreciably increased after tumor necrosis factor inhibitor use? Comment on the article by Solomon et al

Yazici H., Yazici Y.
ARTHRITIS AND RHEUMATISM , vol.64, no.7, pp.2414, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier

46. The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families

Karaca M., Hatemi G., SÜT N., Yazici H.
RHEUMATOLOGY , vol.51, no.6, pp.1053-1060, 2012 (SCI-Expanded) identifier identifier identifier

47. New evidence for the role of interferon regulatory factor 5 in the development of systemic lupus erythematosus: comment on the article by Tada et al

Yazici H., Tascilar K., Kiroglu G., Erar A., DURANSOY M. L.
ARTHRITIS AND RHEUMATISM , vol.63, no.8, pp.2543-2544, 2011 (SCI-Expanded) identifier identifier identifier

48. A proposal from Istanbul University for a new legislation on higher education

Batmaz V., Ozturk R., Vardar O., Yanik M., Yarman S., Yazici H.
YUKSEKOGRETIM DERGISI , vol.1, no.1, pp.6-7, 2011 (ESCI) identifier

49. Behcet's syndrome and micro-organisms

Hatemi G., Yazici H.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , vol.25, no.3, pp.389-406, 2011 (SCI-Expanded) identifier identifier identifier

50. Behcet's Syndrome: Clinical Presentations Affecting Prognosis and Survival

Seyahi E., Tascilar K., Yazici H.
AUTOIMMUNE DISEASES: ACUTE AND COMPLEX SITUATIONS , pp.163-184, 2011 (SCI-Expanded) identifier

51. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

Basu N., Watts R., Bajema I., Baslund B., Bley T., Boers M., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.69, no.10, pp.1744-1750, 2010 (SCI-Expanded) identifier identifier identifier

52. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)

Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

53. EYE DISEASE IN JUVENILE PATIENTS WITH BEHCET'S SYNDROME

Ozyazgan Y., Seyahi E., Sarica A., Ugurlu S., Hatemi G., Yurdakul S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

54. A TWIN STUDY IN BEHCET'S SYNDROME

Masatlioglu S., Seyahi E., Tahir Turanlı E., Fresko I., Gogus F., Senates E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

55. AN AUDIT OF BEHCET'S SYNDROME RESEARCH: A 10-YEAR SURVEY

Esen F., Schimmel E. K., Yazici H., Yazici Y.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

56. A COMPARATIVE STUDY OF CLINICAL, ENDOSCOPIC AND HISTOLOGIC FINDINGS IN PATIENTS WITH GASTROINTESTINAL BEHCET'S DISEASE AND CROHN'S DISEASE

Celik A. F., Hatemi I., Hatemi G., Satir E., Erzin Y., Sisman G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

57. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

58. PULMONARY ARTERY HYPERTENSION IN BEHCET'S SYNDROME

Seyahi E., Baskurt M., Melikoglu M., Akman C., Cebiolgun D., Simsek E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

59. THE PAPULOPUSTULAR LESION/ARTHRITIS CLUSTER OF BEHCET'S SYNDROME IS INDEPENDENTLY FAMILIAL

Karaca M., Hatemi G., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

60. EFFICACY AND SAFETY OF TNF-ALPHA ANTAGONISTS IN THE MANAGEMENT OF BEHCET'S SYNDROME: A SYSTEMATIC REVIEW

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded) identifier

61. Interferon therapy in rheumatic diseases: state-of-the-art 2010

Koetter I., Hamuryudan V., Ozturk Z. E., Yazici H.
CURRENT OPINION IN RHEUMATOLOGY , vol.22, no.3, pp.278-283, 2010 (SCI-Expanded) identifier identifier identifier

62. Comment on: Web resources for rare auto-inflammatory diseases: towards a common patient registry

Yazici Y., Yazici H.
RHEUMATOLOGY , vol.49, no.1, pp.198, 2010 (SCI-Expanded) identifier identifier

63. Endothelial Dysfunction and Atherosclerosis in Behcet's Syndrome

Seyahi E., Fresko I., Yazici H.
BEHCET'S SYNDROME , pp.135-148, 2010 (SCI-Expanded) identifier

64. Informed consent: time for more transparency

Yazici Y., Yazici H.
ARTHRITIS RESEARCH & THERAPY , vol.12, no.3, 2010 (SCI-Expanded) identifier identifier

65. Introduction: Dedicated Mondays and an Acquaintance-Based View of Behcet's Syndrome

Yazici H.
BEHCET'S SYNDROME , pp.1-5, 2010 (SCI-Expanded) identifier identifier

66. Prognosis in Behcet's Syndrome

Seyahi E., Yazici H.
BEHCET'S SYNDROME , pp.285-298, 2010 (SCI-Expanded) identifier identifier

67. Low-dose natural human interferon-alpha lozenges in the treatment of Behcet's syndrome

Kilic H., Zeytin H. E., KORKMAZ C., Mat C., Gül A., Cosan F., et al.
RHEUMATOLOGY , vol.48, no.11, pp.1388-1391, 2009 (SCI-Expanded) identifier identifier identifier

68. Efficacy and safety of TNF-alpha antagonists in the management of Behcet's syndrome - a systematic survey

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.27, no.5, pp.736, 2009 (SCI-Expanded) identifier

69. Behcet's syndrome (BS): an update

Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.27, no.5, pp.730, 2009 (SCI-Expanded) identifier

70. Common MEFV mutations and polymorphisms in an elderly population: an association with E148Q polymorphism and rheumatoid factor levels

Turanli E. T., Beger T., Erdincler D., Curgunlu A., Karaman S., Karaca E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.27, no.2, pp.340-343, 2009 (SCI-Expanded) identifier

71. Treatment strategies for Behcet's disease

Fresko I., Yazici H.
EXPERT OPINION ON PHARMACOTHERAPY , vol.9, no.18, pp.3211-3219, 2008 (SCI-Expanded) identifier identifier identifier

72. Comment on "Cardiac Behcet Disease Presenting as Aortic Valvulitis/Aortitis or Right Heart Inflammatory Mass: A Clinicopathologic Study of 12 Cases"

Hamuryudan V., Seyahi E., Yazici H.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY , vol.32, no.12, pp.1914-1915, 2008 (SCI-Expanded) identifier identifier identifier

73. Behcet's Syndrome Is Not So Rare: Why Do We Need to Know?

Yazici H., Seyahi E., Yurdakul S.
ARTHRITIS AND RHEUMATISM , vol.58, no.12, pp.3640-3643, 2008 (SCI-Expanded) identifier identifier identifier

74. The unique features of vasculitis in Behcet's syndrome

Melikoglu M., Kural-Seyahi E., Tascilar K., Yazici H.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY , vol.35, pp.40-46, 2008 (SCI-Expanded) identifier identifier identifier

75. Behcet's syndrome

Yurdakul S., Yazici H.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , vol.22, no.5, pp.793-809, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

76. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , vol.38, no.1, pp.1-12, 2008 (SCI-Expanded) identifier identifier identifier

77. THE LONG TERM PROGNOSIS OF BEHCET'S SYNDROME AMONG MEN WITH SKIN-MUCOSA INVOLVEMENT AT ONSET: RE-EVALUATION OF A COHORT OF PATIENTS ENROLLED IN A CONTROLLED TRIAL

Hamuryudan V., Hatemi G., Tascilar K., Ozyazgan Y., Seyahi E., Mat C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.4, 2008 (SCI-Expanded) identifier

78. PPD REACTION IS NOT AUGMENTED IN BEHCET'S SYNDROME PATIENTS

Hatemi G., Melikoglu M., Sut N., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.4, 2008 (SCI-Expanded) identifier

79. INFLIXIMAB IN 10 PATIENTS WITH BEHCET'S OCULAR INVOLVEMENT

Ozyazgan Y., Sarica A., Seyahi E., Hatemi G., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.4, 2008 (SCI-Expanded) identifier

80. Increased enthesopathy among Behcet's syndrome patients with acne and arthritis

Hatemi G., Fresko I., Tascilar K., Yazici H.
ARTHRITIS AND RHEUMATISM , vol.58, no.5, pp.1539-1545, 2008 (SCI-Expanded) identifier identifier identifier

81. Intraobserver and interobserver agreements of leg circumference measurements by tape measure based on 3 reference points

Tunc R., Caglayan-Tunc A., Kisakol G., Unler G. K., Hidayetoglu T., Yazici H.
ANGIOLOGY , vol.58, no.5, pp.593-596, 2007 (SCI-Expanded) identifier identifier identifier

82. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

Hellmich B., Flossmann O., Gross W. L., Bacon P., Cohen-Tervaert J. W., Guillevin L., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.66, no.5, pp.605-617, 2007 (SCI-Expanded) identifier identifier identifier

83. Infliximab does not suppress the tuberculin skin test (purified protein derivative)

Hatemi G., Melikoglu M., Fresko I., Masatlioglu S., Tascilar K., Yazici H.
JOURNAL OF RHEUMATOLOGY , vol.34, no.3, pp.474-480, 2007 (SCI-Expanded) Sustainable Development identifier identifier identifier

84. Behcet's syndrome: disease manifestations, management, and advances in treatment

Yazici H., Fresko I., Yurdakul S.
NATURE CLINICAL PRACTICE RHEUMATOLOGY , vol.3, no.3, pp.148-155, 2007 (SCI-Expanded) identifier identifier identifier

85. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers

Melikoglu M., Uysal S., Krueger J. G., Kaplan G., Gogus F., Yazici H., et al.
JOURNAL OF IMMUNOLOGY , vol.177, no.9, pp.6415-6421, 2006 (SCI-Expanded) identifier identifier identifier

86. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al

Yazici Y., Yazici H.
ARTHRITIS AND RHEUMATISM , vol.54, no.9, pp.3061-3062, 2006 (SCI-Expanded) identifier identifier identifier

87. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?

Akman-Demir G., Gul A., Gurol E., Ozdogan H., Bahar S., Oge A. E., et al.
JOURNAL OF NEUROLOGY , vol.253, no.7, pp.928-934, 2006 (SCI-Expanded) identifier identifier identifier

88. A double-blind trial of depot corticosteroids in Behcet's syndrome

Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., et al.
RHEUMATOLOGY , vol.45, no.3, pp.348-352, 2006 (SCI-Expanded) identifier identifier identifier

89. Fibrinolytic activity and d-dimer levels in Behcet's syndrome

Yurdakul S., Hekim N., Soysal T., Fresko I., Bavunoglu I., Ozbakir F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.23, no.4, 2005 (SCI-Expanded) identifier identifier identifier

90. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.
JOURNAL OF RHEUMATOLOGY , vol.32, no.1, pp.98-105, 2005 (SCI-Expanded) identifier identifier identifier

91. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center

Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.
MEDICINE , vol.82, no.1, pp.60-76, 2003 (SCI-Expanded) identifier identifier identifier

92. Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: An open study

Hamuryudan V., Ozyazgan Y., Fresko Y., Mat C., Yurdakul S., Yazici H.
ISRAEL MEDICAL ASSOCIATION JOURNAL , vol.4, no.11, pp.928-930, 2002 (SCI-Expanded) identifier identifier identifier

93. A double-blind trial of colchicine in Behcet's syndrome

Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., et al.
ARTHRITIS AND RHEUMATISM , vol.44, no.11, pp.2686-2692, 2001 (SCI-Expanded) Sustainable Development identifier identifier identifier

94. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome

Tunc R., Uluhan A., Melikoglu M., Ozyazgan Y., Ozdogan H. A., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.19, no.5, 2001 (SCI-Expanded) identifier identifier identifier

95. Absence of ANCA in Behcçet’s Syndrome with Large Vessel Involvement

Tunç U., ÖZBAKIR F., Çağlayan A., Altıparmak M., Yargan P., FRESKO İ., et al.
INTERNATIONAL JOURNAL OF ACAROLOGY , vol.10, pp.260-262, 2001 (Scopus)

96. Behçet sendromunda antimikobakteriyal antikorlar

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.
İnfeksiyon Dergisi(Turkish Journal of Infection) , vol.13, no.4, pp.527-529, 1999 (Peer-Reviewed Journal)

97. Neutrophil chemotaxis in Behcet's syndrome

Tüzün B., Tuzun Y., Mat C., Yurdakul S., Hamuryudan V., Yazici H., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.58, no.10, pp.658, 1999 (SCI-Expanded) identifier identifier identifier

98. Behcet's syndrome - The cerrahpasa experience

Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.
RHEUMADERM , vol.455, pp.135-140, 1999 (SCI-Expanded) identifier identifier identifier

99. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial

Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., et al.
ANNALS OF INTERNAL MEDICINE , vol.128, no.6, pp.443-451, 1998 (SCI-Expanded) identifier identifier identifier

100. Wound healing in Behcet's syndrome

Mat M. C., Nazarbaghi M., Tuzun Y., Hamuryudan V., Hızlı N., Yurdakul S., et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.37, no.2, pp.120-123, 1998 (SCI-Expanded) identifier identifier identifier

101. Azathioprine in Behcet's syndrome - Effects on long-term prognosis

Hamuryudan V., Ozyazgan Y., Hızlı N., Mat C., Yurdakul S., Tuzun Y., et al.
ARTHRITIS AND RHEUMATISM , vol.40, no.4, pp.769-774, 1997 (SCI-Expanded) identifier identifier identifier

102. Treatment of Behcet disease with pentoxifylline

Hamuryudan V., Ozyazgan Y., Yazici H.
ANNALS OF INTERNAL MEDICINE , vol.126, no.6, pp.494, 1997 (SCI-Expanded) identifier identifier

103. Paterji pozitifliğinin pikür süresi ile ilişkisi

MAT M. C., GÖKLER G., YURDAKUL S., TÜZÜN Y., YAZICI H., HAMURYUDAN V., et al.
CERRAHPAŞA TIP DERGİSİ , vol.27, pp.94-97, 1996 (Peer-Reviewed Journal)

104. The ten-year mortality in Behcet's syndrome

Yazici H., Başaran G., Hamuryudan V., Hızlı N., Yurdakul S., Mat C., et al.
BRITISH JOURNAL OF RHEUMATOLOGY , vol.35, no.2, pp.139-141, 1996 (SCI-Expanded) identifier identifier identifier

105. Diabetic sclerodactyly

Tüzün B., Tüzün Y., Dinççağ N., Minareci Ö., Öztürk S., Yilmaz M., et al.
Diabetes Research and Clinical Practice , vol.27, no.2, pp.153-157, 1995 (SCI-Expanded) Sustainable Development identifier identifier identifier

106. SYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME

HAMURYUDAN V., Moral F., YURDAKUL S., MAT C., TUZUN Y., OZYAZGAN Y., et al.
JOURNAL OF RHEUMATOLOGY , vol.21, no.6, pp.1098-1100, 1994 (SCI-Expanded) Sustainable Development identifier

107. Behçet hastalığı

YAZICI H., YURDAKUL S., TÜZÜN Y., ÖZYAZGAN Y., MAT M. C., HAMURYUDAN V.
BİLİM VE TEKNİK , no.314, pp.25-29, 1994 (Peer-Reviewed Journal)

108. URATE CRYSTAL TEST IN BEHCETS-SYNDROME

Çakır N., İmeryüz N., Suna D. C., Gözükara Y., SERDAROGLU S., Mert A., et al.
BRITISH JOURNAL OF RHEUMATOLOGY , vol.32, no.12, pp.1112-1114, 1993 (SCI-Expanded) identifier

109. ACUTE FEBRILE NEUTROPHILIC DERMATOSIS (SWEETS SYNDROME) ASSOCIATED WITH BEHCETS-DISEASE

Oğuz O., SERDAROGLU S., TUZUN Y., Erdoğan N., YAZICI H., Savaşkan H.
INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.31, no.9, pp.645-646, 1992 (SCI-Expanded) identifier identifier identifier

110. Maffucci sendromu: MR, BT, US, Direkt grafi ve Flebografi özellikleri

KOÇER N., KORMAN M. U., YAZICI H., BERKMEN T., NUMAN F.
Türk Radyoloji Dergisi , no.27, pp.16-21, 1992 (Peer-Reviewed Journal)

111. A CONTROLLED TRIAL OF AZATHIOPRINE IN BEHCETS SYNDROME

YAZICI H., Pazarlı H., Barnes C. G., TUZUN Y., OZYAZGAN Y., Silman A., et al.
NEW ENGLAND JOURNAL OF MEDICINE , vol.322, no.5, pp.281-285, 1990 (SCI-Expanded) identifier identifier identifier

112. Paterji testinde pikür derinliği ve dermal travma derecesinin sonuç üzerindeki isi (İntra-epidermal ve dermal paterji uygulaması)

İşçimen A., Tozakı S., SERDAROĞLU S., TÜZÜN Y., YURDAKUL S., Hamuryudan V., et al.
Deri Hast Frengi Arş , vol.23, pp.175-181, 1989 (Peer-Reviewed Journal)

113. PROGNOSTIC VALUE OF HLA B5 ANTIGEN IN ISOLATED ANTERIOR UVEITIS IN BEHCETS-DISEASE

OGUZ V., Pazarlı H., OZYAZGAN Y., YAZICI H., YURDAKUL S., TUZUN Y., et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.12, pp.431-432, 1989 (SCI-Expanded) identifier

114. THE HLA ASSOCIATION OF LEPROMATOUS LEPROSY AND BORDERLINE LEPROMATOUS LEPROSY IN TURKEY - A PRELIMINARY-STUDY

MAT M. C., YAZICI H., ÖZBAKIR F., TUZUN Y.
INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.27, no.4, pp.246-247, 1988 (SCI-Expanded) identifier identifier identifier

115. THE PREVALENCE OF BEHCET SYNDROME IN A RURAL AREA IN NORTHERN TURKEY

YURDAKUL S., GÜNAYDIN İ., TUZUN Y., TANKURT N., Pazarlı H., OZYAZGAN Y., et al.
JOURNAL OF RHEUMATOLOGY , vol.15, no.5, pp.820-822, 1988 (SCI-Expanded) identifier identifier identifier

116. Behçet hastalığında deri belirtileri

TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., İşçimen A., Yurdakul S., Altaç M., et al.
Deri Hast Frengi Arş , vol.22, pp.29-35, 1988 (Peer-Reviewed Journal)

117. SHORT-TERM CYCLOSPORINE-A TREATMENT OF BEHCETS-DISEASE

Müftüoğlu A., Pazarlı H., YURDAKUL S., YAZICI H., Ülkü B. Y., TUZUN Y., et al.
BRITISH JOURNAL OF OPHTHALMOLOGY , vol.71, no.5, pp.387-390, 1987 (SCI-Expanded) Sustainable Development identifier identifier identifier

118. VONWILLEBRAND-FACTOR IN BEHCETS-SYNDROME

YAZICI H., HEKİM N., ÖZBAKIR F., YURDAKUL S., TUZUN Y., Pazarlı H., et al.
JOURNAL OF RHEUMATOLOGY , vol.14, no.2, pp.305-306, 1987 (SCI-Expanded) identifier

119. Behçet hastalığı

YAZICI H., Müftüoğlu A., YURDAKUL S., Ülkü B. Y., TÜZÜN Y., Pazarlı H.
DOĞA , vol.11, pp.153-169, 1987 (Peer-Reviewed Journal)

120. BEHCETS-DISEASE - RELATION OF SERUM C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION-RATES TO DISEASE-ACTIVITY

Müftüoğlu A., YAZICI H., YURDAKUL S., TUZUN Y., Pazarlı H., Güngen G., et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.25, no.4, pp.235-239, 1986 (SCI-Expanded) identifier identifier identifier

121. HISTOCOMPATIBILITY ANTIGENS (HLA) IN ACUTE LYMPHOCYTIC-LEUKEMIA

ULUKUTLU L., YAZICI H., CAM H., ESEN E., OZBAKIR F.
TURKISH JOURNAL OF PEDIATRICS , vol.28, no.2, pp.111-114, 1986 (SCI-Expanded) identifier identifier identifier

122. Behçet astalığına bağlı göz tutulumlarında görülen klinik tipleri

Pazarlı H., Özyazgan Y., YAZICI H., Bahçecioğlu H., Yurdakul S., Müftüoğlu A., et al.
Deri Hast Frengi Arş , vol.20, pp.171-174, 1986 (Peer-Reviewed Journal)

123. Behçet hastalığı: Damar tutulmasının özellikleri

Müftüoğlu A., YURDAKUL S., YAZICI H., ÖZDOĞAN H., TÜZÜN Y., Pazarlı H., et al.
BAVS VAKIF GUREBA HASTANESİ DERGİSİ , vol.12, pp.117-124, 1985 (Peer-Reviewed Journal)

124. Behçet hastlığı-Damar tutulmasının özellikleri

Müftüoğlu A., YURDAKUL S., YAZICI H., Ozdogan H., TÜZÜN Y., Pazarlı H., et al.
Bezm_i Alem Valide Sultan Vakıf Guraba Hastanesi Dergisi , vol.12, pp.117-124, 1985 (Peer-Reviewed Journal)

125. MALE-PATIENTS WITH BEHCETS SYNDROME HAVE STRONGER PATHERGY REACTIONS

YAZICI H., TUZUN Y., Tanman A. B., YURDAKUL S., SERDAROGLU S., Pazarlı H., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.3, no.2, pp.137-141, 1985 (SCI-Expanded) identifier identifier identifier

126. A COMPARATIVE-STUDY OF THE PATHERGY REACTION AMONG TURKISH AND BRITISH PATIENTS WITH BEHCETS-DISEASE

YAZICI H., CHAMBERLAIN M., TUZUN Y., YURDAKUL S., Müftüoğlu A.
ANNALS OF THE RHEUMATIC DISEASES , vol.43, no.1, pp.74-75, 1984 (SCI-Expanded) identifier identifier identifier

127. INFLUENCE OF AGE OF ONSET AND PATIENTS SEX ON THE PREVALENCE AND SEVERITY OF MANIFESTATIONS OF BEHCETS SYNDROME

YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., OZYAZGAN Y., ÖZDOĞAN H., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.43, no.6, pp.783-789, 1984 (SCI-Expanded) identifier identifier identifier

128. THE ARTHRITIS OF BEHCETS-DISEASE - A PROSPECTIVE-STUDY

YURDAKUL S., YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., ALTAÇ M., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.42, no.5, pp.505-515, 1983 (SCI-Expanded) identifier identifier identifier

129. THE VALIDITY OF THE PATHERGY TEST (NONSPECIFIC SKIN HYPERREACTIVITY) IN BEHCETS-DISEASE - A DOUBLE-BLIND-STUDY BY INDEPENDENT OBSERVERS

ALTAÇ M., TUZUN Y., YURDAKUL S., BİNYILDIZ P., YAZICI H.
ACTA DERMATO-VENEREOLOGICA , vol.62, no.2, pp.158-159, 1982 (SCI-Expanded) identifier

130. Kriyoglobulinemi: iki yöntemin kıyaslanması ve Behçet hastalığında kriyoglobulinler

ÖZBAKIR F., YAZICI H., ATAMAN N., Ülkü B. Y., Pazarlı H., TÜZÜN Y., et al.
CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , vol.12, no.4, pp.423-427, 1981 (Peer-Reviewed Journal)

131. Silivri Fener köyü ve yöresinde Behçet hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem

DEMİRHİNDİ O., YAZICI H., BİNYILDIZ P., DAYIOĞLU N., TÜZÜN Y., ALTAÇ M., et al.
CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , vol.12, no.4, pp.509-514, 1981 (Peer-Reviewed Journal)

132. İki Yöntemin Kıyaslaması ve Behcet Hastalığında Kriyoglobulinler

ÖZBAKIR F., YAZICI H., Ataman U. K., Yalçın Ülkü P. B., Pazarlı P., Tüzün P. Y., et al.
Cerrahpaşa Tıp Fakültesi Dergisi , vol.12, no.3, pp.423-427, 1981 (Peer-Reviewed Journal)

133. A METHOD OF MEASURING SKIN-LESIONS

TUZUN Y., YAZICI H.
ARCHIVES OF DERMATOLOGY , vol.117, no.4, pp.192, 1981 (SCI-Expanded) identifier

134. BEHCETS-DISEASE - LACK OF CORRELATION OF CLINICAL MANIFESTATIONS WITH HLA ANTIGENS

Müftüoğlu A., YAZICI H., YURDAKUL S., Pazarlı H., OZYAZGAN Y., TUZUN Y., et al.
TISSUE ANTIGENS , vol.17, no.2, pp.226-230, 1981 (SCI-Expanded) identifier identifier identifier

135. USEFULNESS OF HLA DETERMINATION AND PATHERGY TEST IN THE DIAGNOSIS OF UVEITIS IN TURKEY

OZYAZGAN Y., Pazarlı H., YAZICI H., YURDAKUL S., TUZUN Y., ALTAÇ M., et al.
BRITISH JOURNAL OF OPHTHALMOLOGY , vol.65, no.11, pp.798-799, 1981 (SCI-Expanded) identifier identifier identifier

136. LOCALIZED MYOSITIS IN BEHCETS-DISEASE

YAZICI H., TUZUNER N. N., TUZUN Y., YURDAKUL S.
ARTHRITIS AND RHEUMATISM , vol.24, no.4, pp.636, 1981 (SCI-Expanded) identifier identifier identifier

137. Behçet Hastalığı: I. Hematolojik ve immunolojik özellikleri

Müftüoğlu A., Ülkü B. Y., EZER G., GÜRSOY A., YAZICI H., YURDAKUL S., et al.
CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , vol.11, no.3, pp.347-353, 1980 (Peer-Reviewed Journal)

138. NONSPECIFIC SKIN HYPER-REACTIVITY IN BEHCETS DISEASE

TUZUN Y., ALTAÇ M., YAZICI H., BAŞÖZ A., YURDAKUL S., Pazarlı H., et al.
HAEMATOLOGICA , vol.65, no.3, pp.395-398, 1980 (SCI-Expanded) identifier

139. BEHCETS DISEASE AS SEEN IN TURKEY

YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., YALCIN B., Müftüoğlu A.
HAEMATOLOGICA , vol.65, no.3, pp.381-383, 1980 (SCI-Expanded) identifier identifier identifier

140. A DOUBLE-BLIND STUDY OF COLCHICINE IN BEHCETS DISEASE

AKTULGA E., ALTAÇ M., Müftüoğlu A., OZYAZGAN Y., Pazarlı H., TUZUN Y., et al.
HAEMATOLOGICA , vol.65, no.3, pp.399-402, 1980 (SCI-Expanded) identifier

141. HEMATOLOGICAL AND IMMUNOLOGICAL FEATURES OF BEHCETS DISEASE

YALCIN B., GÜRSOY A., EZER G., Pazarlı H., TUZUN Y., YURDAKUL S., et al.
HAEMATOLOGICA , vol.65, no.3, pp.390-394, 1980 (SCI-Expanded) identifier

142. THE COMBINED USE OF HLA-B5 AND THE PATHERGY TEST AS DIAGNOSTIC MARKERS OF BEHCETS-DISEASE IN TURKEY

YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., YURDAKUL S., Müftüoğlu A.
JOURNAL OF RHEUMATOLOGY , vol.7, no.2, pp.206-210, 1980 (SCI-Expanded) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 69

1. Sex factor and Behçet's syndrome

YAZICI H., HEKİM N., TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., ÖZ F., et al.
INTERNATIONAL CONFERENCE OF BEHÇET'S DISEASE, United Kingdom, pp.205, (Full Text)

2. FACTORS ASSOCIATED WITH DAMAGE PROGRESSION IN BEHCET'S SYNDROME UVEITIS

Ozyazgan Y., Ucar D., Erdogan M., Ozguler Y., Hatemi G., Yurdakul S., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.1187-1188, (Summary Text) identifier

3. THE OMERACT CORE DOMAIN SET FOR CLINICAL TRIALS IN BEHCET'S SYNDROME

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Shea B., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.431, (Summary Text) identifier

4. HYPERCOAGULABILITY AS A CAUSE OF THROMBOSIS IN BEHCET'S SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

Guzelant G., Yurttas B., Esatoglu S. N., Hamuryudan V., Yazici H., Hatemi G.
19th International Vasculitis and ANCA Workshop, Pennsylvania, United States Of America, 7 - 10 April 2019, vol.58, pp.139, (Summary Text) identifier

5. Could neurological involvement in Behcet's Disease occur atypically?

Siva A., Esatoglu S. N., Uygunoglu U., Ozguler Y., Hatemi G., Tutuncu M., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text) identifier

6. PAPULOPUSTULAR LESIONS ACCORDING TO AGE, SEX AND LOCALIZATION IN BEHCET'S SYNDROME PATIENTS COMPARED HEALTHY AND DISEASED CONTROLS

Kutlubay Z., Ozguler Y., Hatemi G., Tascilar K., Mat C., Yazici H.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.90-91, (Summary Text) identifier

7. IDENTIFYING CORE DOMAINS FOR BEHCETS SYNDROME TRIALS BY A DELPHI EXERCISE

Meara A. S., Ozguler Y., Mahr A., Direskineli H., Gül A., Yazici Y., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.95, (Summary Text) identifier

8. RELATIONSHIP BETWEEN MENSTRUATION AND SYMPTOMS OF BEHCET'S SYNDROME

Guzelant G., Ozguler Y., Esatoglu S. N., Karatemiz G., Ozdogan H., Yurdakul S., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.92, (Summary Text) identifier

9. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.94, (Summary Text) identifier

10. CAN WE DIFFERENTIATE TAKAYASU'S ARTERITIS FROM ATHEROSCLEROSIS USING CAROTID ARTERY DOPPLER USG?

Seyahi E., Esatoglu S. N., Ugurlu S., Keskin F. E., Cetinkaya F., Melikoglu M., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.46-47 identifier

11. SYSTEMATIC REVIEW ON THE TREATMENT OF SKIN, MUCOSA AND JOINT INVOLVEMENT OF BEHCET'S SYNDROME INFORMING THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S SYNDROME

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Olivieri I., Yazici H., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.89, (Summary Text) identifier

12. Systems Approach To The Study Of the Microbiome and Inflammatory Pathways In Oral Ulcer Tissue From Patients With Active Behcet's Syndrome (BS)

Sibley C., Hatemi G., Yazici Y., Liu Y., Brooks S., Yazici H., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

13. Venous Claudication Is A Severe and Frequent Symptom In BEHCET'S Syndrome

Ugurlu S., Seyahi E., Oktay V., Yigit Z., Kucukoglu S., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

14. Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

15. An Outcome Survey Of 40 Patients With Budd-Chiari Syndrome Due To BEHCET'S Syndrome Followed By A Single Center

Seyahi E., Ugurlu S., Caglar E., Kantarci F., Sonsuz A., Yurdakul S., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

16. Apremilast For The Treatment Of Behcet's Syndrome: A Phase II Randomized, Placebo-Controlled, Double-Blind Study

Hatemi G., Melikoglu M., Tunc R., KORKMAZ C., ÖZTÜRK B. T., Mat C., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

17. Fertility In Behcet's Syndrome: Structured Interview In A Multidisciplinary Center

Saygin C., Uzunaslan D., Hatemi G., Tascilar K., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

18. A CT Evaluation Of Pulmonary and Cardiac Lesions In BEHCET'S Syndrome Patients Without Pulmonary Symptoms

Seyahi E., Olgun D. C., Ugurlu S., Hanci I., Takahashi R., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) identifier

19. Characteristics, Treatment and Outcome of Gastrointestinal Involvement in Behcet's Syndrome: Experience in A Dedicated Center

Hatemi I., Hatemi G., Erzin Y., Celik A. F., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 November 2012, vol.64, (Summary Text) identifier

20. Aortic and Coronary Calcifications in Takayasu Arteritis

Seyahi E., Ucgul A., Ugurlu S., Akman C., Olgun D. C., Yurdakul S., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 November 2012, vol.64 identifier

21. The Clinical Course of the Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Ozguler Y., Melikoglu M., Cetinkaya F., Ugurlu S., Seyahi E., Tascilar K., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 November 2012, vol.64, (Summary Text) identifier

22. Further Evidence On Biased Cancer Risk Estimation in Studies Comparing A Subpopulation to the General Population.

Tascilar K., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 November 2012, vol.64 Sustainable Development identifier

23. Effect of Colchicine On Cholesterol Levels in Patients with Familial Mediterranean Fever and Behcet's Syndrome

Ugurlu S. L., Seyahi E., Hanci I., Ozdogan H., Masatlioglu-Pehlivan S., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 November 2012, vol.64, (Summary Text) identifier

24. Management and Prognosis of Non-Pulmonary Large Arterial Disease in Behcet's Syndrome: A Reappraisal of 25 Patients From a Single Center

Tuzun H., Seyahi E., Arslan C., Hamuryudan V., Besirli K., Yazici H.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, United States Of America, 4 - 09 November 2011, vol.63, (Summary Text) identifier

25. The "Table-1 p Value" Issue; Baseline Group Comparison Is Inappropriately Omitted in Non-Randomized Studies

Tascilar K., Atac E., Esen F., Yazici H.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, United States Of America, 4 - 09 November 2011, vol.63, (Summary Text) identifier

26. A Possible Source of Error in the Method of Cancer Risk Estimation in Patients with Rheumatoid Arthritis

Yazici H., Tascilar K., Yazici Y., Kiroglu G., Duransoy L., Erar A.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, United States Of America, 4 - 09 November 2011, vol.63, (Summary Text) Sustainable Development identifier

27. THE FREQUENCY OF FIBROMYALGIA IS NOT INCREASED AMONG NURSES

Yurdakul S., Findikoglu S. Y., Hatemi G., Suzen S., Yazici H.
Conference on Excellence in Rheumatology, İstanbul, Turkey, 17 - 19 February 2011, vol.50, (Summary Text) identifier

28. WORK DISABILITY IN BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Ugurlu S., Yazici H.
Conference on Excellence in Rheumatology, İstanbul, Turkey, 17 - 19 February 2011, vol.50, (Summary Text) identifier

29. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.
Conference on Excellence in Rheumatology, İstanbul, Turkey, 17 - 19 February 2011, vol.50, (Summary Text) identifier

30. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Yurdakul S., Mat C., Tascilar K., Ozyazgan Y., et al.
Conference on Excellence in Rheumatology, İstanbul, Turkey, 17 - 19 February 2011, vol.50, (Summary Text) identifier

31. V617F JAK2 mutations are not associated with thrombosis among patients with Behçet’s Syndrome.

AR C., HATEMİ G., EKİZOĞLU ERATAK S., SAÇLI S., BİLGEN H., BUYRU A. N., et al.
14th International Conference on Behçet`s Disease, Londra, United Kingdom, 8 - 10 July 2010, (Summary Text)

32. Kronik Hastalığı Olmayan Yaşlı Topluluğunda İmmün Gen Belirteçlerinin Analizleri: IL-6, IL-10 ve TNF-A Sonuçları

TAHİR TURANLI E., ERDİNÇLER Ü. D., ÇURGUNLU A., BOLAYIRLI İ. M., SEYAHİ E., BEĞER T., et al.
Akademik Geriatri Kongresi,, Antalya, Turkey, 20 - 24 May 2009, pp.158-159, (Full Text)

33. Tümör Nekroz Faktörü Alfa Antogonistleri ile Tedavi Quantıferon-TB Gold Testinin sonucunu etkilemez

HATEMİ G., MELİKOĞLU M., ÖZBAKIR F., Batumlu M., Taşçılar K., Çevirgen D., et al.
IX.Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2008, pp.120, (Full Text)

34. Effect of immunosuppressive treatment on skin pathergy reaction in Behcet's disease

Tascilar K., Melikoglu M., Baran A., Gogus F., Hatemi G., Yazici H.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Costa Rica, 24 - 29 October 2008, vol.58, (Summary Text) identifier

35. Quantiferon-TB gold blood test in rheumatoid arthritis patients using TNF-alpha antagonists

Hatemi G., Melikoglu M., Tascilar K., Batumlu M., Ozbakir F., Cevirgen D., et al.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Costa Rica, 24 - 29 October 2008, vol.58, (Summary Text) identifier

36. Large vessel involvement in Behcet's syndrome: A retrospective survery

Melikoglu M., UĞURLU S., Tascilar K., Caglar E., Seyahi E., Hamuryudan V., et al.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Costa Rica, 24 - 29 October 2008, vol.58 identifier

37. Yaşlanma ve MEFV Mutasyonları",

TAHİR TURANLI E., BEGER T., ERDİNÇLER Ü. D., ÇURGUNLU A., KARAMAN S., KARACA E., et al.
XIX Ulusal İmmunoloji Kongresi, Antalya, Turkey, 21 - 24 November 2007, pp.218

38. TNF inhibitors (TNFi): Useful additional therapy to methotrexate (MTX) in rheumatoid arthritis patients with severe disease.

Yazici Y., Yazici H.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 November 2006, vol.54, (Summary Text) identifier

39. Alternative treatments in colchicine-resistant patients with familial mediterranean fever (FMF).

Seyahi E., Ozdogan H., Yazici H.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 November 2006, vol.54 identifier

40. Behcet's syndrome (BS) patients with acne and arthritis (BS-AA) have more enthesopathy than BS patients without acne and arthritis (BS-nonAA).

Hatemi G., Fresko I., Tascilar K., Yazici H.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 November 2006, vol.54, (Summary Text) identifier

41. Differences in the frequency of 52kDa and 60kDa anti-SSA/Ro antibodies among primary Sjögren’s Syndrome. Systemic Lupus Eryhematosus and Systemic Lupus Erythematosus with secondary Sjögren’s Syndrome

ÖZBAKIR F., FRESKO İ., SEYAHİ E., Masatlıoğlu S., YAZICI H.
Twelfth International Congress of Histochemistry and Cytochemistry meeting jointly with The Histochemical Society ICHC 2004, San Diago, United States Of America, 24 - 28 July 2004, vol.12, pp.3, (Summary Text)

42. Anti-Sacchcaromyces cerevisiae antibodies(ASCA) in Behçet’s

FRESKO İ., UĞURLU S., ÖZBAKIR F., ÇELİK A. F., YURDAKUL S., YAZICI H.
Annual European Congress of Rheumatology. EULAR 2003, Lizbon, Portugal, 18 - 21 June 2003, vol.62, no.1, pp.209

43. Fibrinolytic activity and d-dimer levels of in Behcçet’s Syndrome

YURDAKUL S., Hekim D. N., SOYSAL T., MELİKOĞLU M., ÖZBAKIR F., FRESKO İ., et al.
Annual European Congress of Rheumatology.EULAR 2003, Lizbon, Portugal, 18 - 21 June 2003, vol.62, no.1, pp.210-211, (Summary Text)

44. The characteristic of anti-Topoisomerase I antibodies in Systemic Lupus Erythematosus(SLE) patients

ÖZBAKIR F., FRESKO İ., YILMAZER S., YAZICI H.
15th european immunology congress efis2003, Rodos, Greece, 8 - 12 June 2003, vol.15, pp.86, (Summary Text)

45. Absence of ANCA in Behçet’s Syndrome with Large Vessel Involvement

Tunç R., ÖZBAKIR F., Çağlayan A., Altıparmak M., FRESKO İ., YAZICI H.
Annual European Congress of Rheumatology. EULAR 2002, Stockholm, Switzerland, 12 - 15 June 2002, vol.61, no.1, pp.215

46. Myeloperoxidase activity of Neutrophils Exposed to Monosodium Ürate in Behçets Syndrome

MELİKOĞLU M., ÖZBAKIR F., Hekim C., Hekim D. N., YAZICI H., FRESKO İ., et al.
The fifth Korea;Turkey Joint Meeting of Behçet”s Disease, İstanbul, Turkey, 06 September 1999, vol.1, pp.18, (Summary Text)

47. Changes in Blood and Haemoreological Parameters in Behcet Disease

ÖZDEMİR S., DURSUN Ş., HAMURYUDAN V., YAZICI H.
International Congress on Thrombosis Research, Turkey, pp.569-570, (Summary Text)

48. Behçet Hastalığında Serum Çinko, Bakır ve Demir Elementleri Değişiminin Araştırılması

ÖZDEMİR S., DURSUN Ş., HAMURYUDAN V., YAZICI H.
1.Ulusal Çinko Kongresi, Eskişehir, Turkey, 1 - 04 September 1998, pp.743-748, (Full Text)

49. Vascular involvement in Behcet’s Syndrome: A controlled survey with doppler ultrasonography and CRP, FVIIIRg, ACE levels

HAMURYUDAN V., AKMAN C., ÖZBAKIR F., TÜZÜN K. H., Hızlı U., Ersavash G., et al.
VIth İnternational Conference on Behcet’s Disease, Tunus, Tunisia, 10 - 11 October 1996, vol.7, pp.545, (Summary Text)

50. Anti-mycobacterial antibodies in Behçet’s syndrome.

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.
VIIth International Conference on Behçet’s disease, Tunis, Tunisia, 10 - 11 October 1996, pp.25, (Summary Text)

51. Anti-Scl70 Antibodies in Systemic Lupus Eritematosus(SLE).

YAZICI H., ÖZBAKIR F., YURDAKUL S., ÖZDOĞAN A. H., HAMURYUDAN V., Hızlı U.
IXth EULAR Syposium of Rheumatology, Madrid, Spain, 7 - 10 October 1996, vol.25, no.1, pp.63

52. Behçet Hastalığında Kan Parametreleri ve Hemoreolojik Parametrelerin Değişimi

ÖZDEMİR S., DURSUN Ş., HAMURYUDAN V., YAZICI H.
VIII. Ulusal Biyofizik Kongresi,, Kocaeli, Turkey, pp.10

53. Lymphocytotoxıc Antibodies in Children: Comparison of Healthy with Diseased States.

Çelebi D. A., KASAPÇOPUR Ö., ÖZBAKIR F., ARISOY N., YAZICI H., ÖZDOĞAN A. H.
Second European Conference on Pediatric Autoimmune and Rheumatic Diseases., Pavia, Italy, 7 - 10 September 1994, vol.12, no.10, pp.120, (Summary Text)

54. Sm And Ro Autoantibodies in Turkish Patients with SLE and RA

Moral,MD F., ÖZBAKIR F., Çakır P. N., ÖZDOĞAN A. H., YAZICI H., YURDAKUL S., et al.
XVIIIth ILAR Congress of Rheumatology, Barselona, Spain, 4 - 09 July 1993, vol.20, no.1, pp.126, (Summary Text)

55. Correlation between disease actıvıty and ınterleukin-6 blood levels in systemic lupus erythematosuss, a comparative study with C3, CRP and Fibrinojen

Çakır P. N., Guerne P., Moral,MD F., ÖZBAKIR F., YURDAKUL S., ÖZDOĞAN A. H., et al.
XVIIIth ILAR Congress of Rheumatology, Barselona, Spain, 4 - 09 July 1993, vol.20, no.1, pp.528

56. Sağlıklı Çocuklarda Antinükleer Antikor ve Romatoid Faktör Sıklığı

KASAPÇOPUR Ö., ÖZDOĞAN A. H., ÖZBAKIR F., INGÖL H., SARP A., YAZICI H.
VIII. Ulusal Romatoloji Kongresi, İstanbul, Turkey, 7 - 11 September 1992, vol.7, pp.13, (Summary Text)

57. Sistemik Lupus Eritematosus’da Hastalık Aktivitesi ile İnterlökin-6 Değerleri Arasındaki İlişki

Çakır P. N., Moral, U. F., ÖZBAKIR F., VISCHER T., Guerne P., YAZICI H.
VIII.Ulusal Romatoloji Kongresi, İstanbul, Turkey, 7 - 11 September 1992, vol.8, pp.19, (Summary Text)

58. Türk Sistemik Lupus Eritematosus ve Romatoid Artrit’lilerinde Anti-Ro ve Anti-Sm Antikorları

Moral, U. F., ÖZBAKIR F., Çakır P. N., HAMURYUDAN V., YURDAKUL S., ÖZDOĞAN A. H., et al.
VIII. Ulusal Romatoloji Kongresi, İstanbul, Turkey, 7 - 11 September 1992, vol.8, pp.14, (Summary Text)

59. Frequency of Antinuclear Antibodies and Rheumatoid Factor in Healthy Children

KASAPÇOPUR Ö., ÖZDOĞAN A. H., ÖZBAKIR F., INGÖL H., SARP A., YAZICI H.
Parague International Pediatric Rheumatology Symposium(Pipers), Prague, Czech Republic, 26 - 29 April 1992, vol.4, pp.50, (Summary Text)

60. Lymphocytotoxic Antibodies (LCA) in Family Members of Patients with Behcet’s Syndrome (BS)

Günaydın İ., YAZICI H., ÖZBAKIR F., HAMURYUDAN V., YURDAKUL S.
12th European Congress of Rheumatology, Budabeşte, Hungary, 30 June - 06 July 1991, vol.32, pp.135

61. Behcet Hastaları ve Aile Bireylerinde Lenfositotoksik Antikorlar

Günaydın, U. İ., YAZICI H., ÖZBAKIR F., HAMURYUDAN V., YURDAKUL S.
VII. Ulusal Romatoloji Kongresi, Antalya, Turkey, 30 October - 01 November 1990, vol.6, pp.44

62. Behçet Sendromlu Tek Yumurta İkizleri

HAMURYUDAN V., YURDAKUL S., Hekim D. N., ÖZBAKIR F., YAZICI H.
VII. Ulusal Romatoloji Kongresi, Antalya, Turkey, 30 October - 01 November 1990, vol.6, pp.30, (Summary Text)

63. HLA antigens in recurrent oral ulceration; Evidence aganist a common disease spectrum with Behçet’s syndrome

ÖZBAKIR F., YAZICI H., MAT M. C., TÜZÜN Y., YURDAKUL S., YILMAZER S.
XIth European Congress of Rheumatology Congress, Atina, Greece, 28 June - 04 July 1987, vol.5, no.2, pp.140

64. Rekkuran Aftöz Stomatitde Doku Antijenler

ÖZBAKIR F., MAT M. C., YURDAKUL S., TÜZÜN Y., YAZICI H.
VIII. Ulusal İmmünoloji Kongresi, İstanbul, Turkey, 30 - 31 October 1986, vol.7, pp.9, (Summary Text)

65. Romatoid Artritte Pulse Siklofosfamid Tedavisi

Dede U. H., YURDAKUL S., ÖZBAKIR F., YAZICI H.
VIII. Ulusal İmmünoloji Kongresi, İstanbul, Turkey, 30 September - 01 November 1986, vol.1, pp.28, (Summary Text)

66. Sex factor and Behçet's syndrome

YAZICI H., HEKİM N., TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., ÖZ F., et al.
INTERNATIONAL CONFERENCE OF BEHÇET'S DISEASE, Londra, United Kingdom, 5 - 06 September 1985, pp.205-206

67. Total lymphoid irradiation for the treatment of intractable Behçet's syndrome

YURDAKUL S., YAZICI H., Müftüoğlu A., OKKAN S., TURKAN S., UZEL R., et al.
INTERNATIONAL CONFERENCE ON BEHÇET'S DISEASE, Londra, United Kingdom, 5 - 06 September 1985, pp.307-308, (Full Text)

68. The prevalence of HLA B27 is Increased in Rheumatoid Arthritis in Turkey

YAZICI H., ÖZBAKIR F., YURDAKUL S., Müftüoğlu P. A.
5th. European İmmunology Meeting, İstanbul, Turkey, 1 - 04 June 1982, vol.5, no.33, pp.213, (Summary Text)

69. The prevalence of HLA B5 in recurrent oral ulceration versus Behçet’s disease in Turkey 16-18 March1981

ÖZBAKIR F., YAZICI H., TÜZÜN Y., ÖZDOĞAN A. H., Müftüoğlu P. A.
European Histocompability Training Conference, Strasbourg,, France, 16 - 18 March 1981, no.1, pp.94, (Summary Text)
Books 2

1. Behçet’s syndrome

SEYAHİ E., HATEMİ G., FRESKO İ., MELİKOĞLU M., YAZICI H.
in: Oxford Textbook of Vasculitis (3 ed.), Gene V. Ball, Barri J. Fessler, and S. Louis Bridges, Jr., Editor, Oxford University Press, London , Londra, pp.1-2, 2014

2. Behçet's syndrome with emphasis on clinical genetics and mortality

YAZICI H., ÇİÇEK B., Başaran G., HAMURYUDAN V., ÇAKIR N., DIMITRIATRIS I., et al.
in: The Vasculitides, BM Ansell, PA Bacon, JT Lie, H. Yazici, Editor, Chapman & G.K. Hall & Co., London, pp.199-206, 1996
Metrics

Publication

213

Publication (WoS)

162

Publication (Scopus)

122

Citation (WoS)

4712

H-Index (WoS)

31

Citation (Scopus)

4958

H-Index (Scopus)

31

Project

1

Open Access

1
UN Sustainable Development Goals